Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial-Reference-Cited by-同舟云学术

Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial

Published:2024-04-13 Issue:5 Volume:44 Page:343-355
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Du Yujing,Yu Lixiu,Deng Bin,Li Qinying,Hu Junrui,Li Linjie,Xu Yusen,Song Liangwei,Xie Fang,Wang Yinghui,Chen Yuhao,Liu Chengxin,Zhai Xuejia,Lu Yongning^ORCID

Funder

Key Research and Development Plan of Hubei Province

Chinese Pharmaceutical Association

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40261-024-01359-x.pdf

Reference39 articles.

1. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.

2. Saleem N, Howden CW. Update on the management of helicobacter pylori infection. Curr Treat Options Gastroenterol. 2020;18:476–87.

3. Liu C, Wang Y, Shi J, Zhang C, Nie J, Li S, et al. The status and progress of first-line treatment against Helicobacter pylori infection: a review. Ther Adv Gastroenterol. 2021;14:1756284821989177.

4. Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018;155:1372-1382.e17.

5. Zou Y, Qian X, Liu X, Song Y, Song C, Wu S, et al. The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: a systematic review and meta-analysis. Helicobacter. 2020;25: e12714.